← Leaderboards
Daniel Charytonowicz
Icahn School Of Medicine At Mount Sinai
$198,020
Attributed
$198,020
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $54.5K · FY2021–25$100K$75K$50K$25K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$198,020 · 1
By mechanism
F30$198,020 · 1
Top collaborators
No co-investigators on record.
Most similar at Icahn School Of Medicine At Mount Sinai
Same institution · by research overlap
- Clifford J Rosen$37,701,781
- Talia H Swartz$12,761,069
- Amy Steves Kelley$10,329,454
- Allison Bond$545,400
- Michael Rendl$16,676,175
Others in their field
Other Emerging Leaders on “Disease Progression”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Beth Baseler · Leidos Biomedical Research, Inc.$111,936,677
- Klaus Romero · Critical Path Institute$90,404,592
- Susan Abushakra · Alzheon, Inc.$47,265,244
- John Damon Chodera · Sloan-Kettering Inst Can Research$45,424,821
- Ryan Cirz · Revagenix, Inc.$40,209,479
Research focus
Disease ProgressionAftercareCytotoxic ChemotherapyBar CodesApoptoticBiopsyCancer CellAlcam GeneCancer EtiologyCancer PatientCancer Stem CellCancer TherapyCd44 GeneCell FractionCell LineCellsCancer Drug ResistanceAutomobile DrivingCoculture TechniquesComputerized ToolsCritical PathwaysCryoultramicrotomyCustomDna Repair
Grant awards (4)
Defining and targeting the lung cancer progenitor cell niche using a high-resolution, multi-omics approach$54,538
F30 · FY2025 · CA · contact PI
Defining and targeting the lung cancer progenitor cell niche using a high-resolution, multi-omics approach$52,694
F30 · FY2023 · CA · contact PI
Defining and targeting the lung cancer progenitor cell niche using a high-resolution, multi-omics approach$45,152
F30 · FY2022 · CA · contact PI
Defining and targeting the lung cancer progenitor cell niche using a high-resolution, multi-omics approach$45,636
F30 · FY2021 · CA · contact PI